115 related articles for article (PubMed ID: 33382183)
1. Development of a robust reporter gene assay for measuring the bioactivity of OX40-targeted therapeutic antibodies.
Li M; Wang L; Yu C; Wang J
Luminescence; 2021 Jun; 36(4):885-893. PubMed ID: 33382183
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a reporter gene assay to determine the bioactivity of anti-CTLA-4 monoclonal antibodies.
Liu C; Yu C; Yang Y; Cui Y; Zhang F; Wang L; Wang J
Int Immunopharmacol; 2021 Dec; 101(Pt A):108277. PubMed ID: 34773758
[TBL] [Abstract][Full Text] [Related]
3. A reporter gene assay for measuring the bioactivity of anti-LAG-3 therapeutic antibodies.
Wang L; Yu C; Wang K; Wang J
Luminescence; 2020 Dec; 35(8):1408-1415. PubMed ID: 32598535
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel reporter gene assay to evaluate antibody-dependent cellular phagocytosis for anti-CD20 therapeutic antibodies.
Liu C; Yu C; Yang Y; Huang J; Yu X; Duan M; Wang L; Wang J
Int Immunopharmacol; 2021 Nov; 100():108112. PubMed ID: 34521023
[TBL] [Abstract][Full Text] [Related]
5. A robust reporter assay for the determination of the bioactivity of IL-4R-targeted therapeutic antibodies.
Yu X; Yu C; Wang K; Liu C; Wang L; Wang J
J Pharm Biomed Anal; 2021 May; 199():114033. PubMed ID: 33774455
[TBL] [Abstract][Full Text] [Related]
6. Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodies.
Zhao X; Qian W; Hou S; Wu Y; Guo H; Xu J; Zhang D; Li J; Fu R; Xu M; Wang F
J Pharm Biomed Anal; 2024 Aug; 245():116185. PubMed ID: 38723556
[TBL] [Abstract][Full Text] [Related]
7. Development of a robust reporter gene based assay for the bioactivity determination of IL-5-targeted therapeutic antibodies.
Fu Z; Yu C; Wang L; Gao K; Xu G; Wang W; Cao J; Wang J
J Pharm Biomed Anal; 2018 Jan; 148():280-287. PubMed ID: 29059618
[TBL] [Abstract][Full Text] [Related]
8. Development of a robust reporter gene assay to measure the bioactivity of anti-PD-1/anti-PD-L1 therapeutic antibodies.
Wang L; Yu C; Yang Y; Gao K; Wang J
J Pharm Biomed Anal; 2017 Oct; 145():447-453. PubMed ID: 28735186
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a reliable cell-based reporter gene assay for measuring bioactivities of therapeutic anti-interleukin-23 monoclonal antibodies.
Huang J; Wang L; Yu C; Fu Z; Liu C; Zhang H; Wang K; Guo X; Wang J
Int Immunopharmacol; 2020 Aug; 85():106647. PubMed ID: 32504997
[TBL] [Abstract][Full Text] [Related]
10. Measuring the bioactivity of anti-IL-6/anti-IL-6R therapeutic antibodies: presentation of a robust reporter gene assay.
Yu C; Cao J; Wang L; Yang Y; Ni Y; Wang J
Anal Bioanal Chem; 2018 Nov; 410(27):7067-7075. PubMed ID: 30178083
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a reporter gene assay for bioactivity determination of Anti-CGRP monoclonal antibodies.
Guo X; Yu C; Wang L; Zhang F; Wang K; Huang J; Wang J
Anal Biochem; 2021 Dec; 634():114291. PubMed ID: 34161831
[TBL] [Abstract][Full Text] [Related]
12. A robust and stable reporter gene bioassay for anti-IgE antibodies.
Guo S; Yu C; Wang Y; Zhang F; Cao J; Zheng C; Wang L
Anal Bioanal Chem; 2020 Mar; 412(8):1901-1914. PubMed ID: 32030491
[TBL] [Abstract][Full Text] [Related]
13. Development of a robust reporter gene-based assay for the bioactivity determination of recombinant human follicle stimulating hormone (rhFSH) pharmaceutical products.
Wang LY; Liang CG; Yang HM; Li J; Li ZJ; Zhang H; Lv P; Li Y; Wang JZ
J Pharm Biomed Anal; 2020 Jan; 177():112855. PubMed ID: 31561061
[TBL] [Abstract][Full Text] [Related]
14. [Characterization of Therapeutic Monoclonal Antibodies by Using FcγR-expressing Reporter Cell Lines].
Tada M; Ishii-Watabe A
Yakugaku Zasshi; 2017; 137(7):837-843. PubMed ID: 28674297
[TBL] [Abstract][Full Text] [Related]
15. A reporter gene assay for determining the biological activity of therapeutic antibodies targeting TIGIT.
Fu Z; Liu H; Wang L; Yu C; Yang Y; Feng M; Wang J
Acta Pharm Sin B; 2021 Dec; 11(12):3925-3934. PubMed ID: 35024316
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of a high-affinity chimeric anti-OX40 antibody with potent antitumor activity.
Yang Y; Chai X; Xin W; Wang D; Dai C; Qian F; Yang T
FEBS Lett; 2021 Jun; 595(11):1587-1603. PubMed ID: 33792041
[TBL] [Abstract][Full Text] [Related]
17. A simple and robust reporter gene assay for measuring the bioactivity of anti-RANKL therapeutic antibodies.
Yu C; Wang L; Ni Y; Wang J
RSC Adv; 2019 Dec; 9(69):40196-40202. PubMed ID: 35542634
[TBL] [Abstract][Full Text] [Related]
18. Establishing a novel and sensitive assay for bioactivity determination of anti-CD25 antibodies.
Duan M; Yu C; Yang Y; Fu Z; Liu C; Du J; Li M; Guo S; Yu X; Xu G; Mei Y; Wang L
Heliyon; 2023 Jun; 9(6):e17401. PubMed ID: 37416689
[TBL] [Abstract][Full Text] [Related]
19. Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies.
Cheng ZJ; Garvin D; Paguio A; Moravec R; Engel L; Fan F; Surowy T
J Immunol Methods; 2014 Dec; 414():69-81. PubMed ID: 25086226
[TBL] [Abstract][Full Text] [Related]
20. Lactogenic hormone responsive element reporter gene activation assay for human growth hormone.
Sakatani T; Kaji H; Takahashi Y; Iida K; Okimura Y; Chihara K
Growth Horm IGF Res; 2003 Oct; 13(5):275-81. PubMed ID: 12932749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
